Literature DB >> 12479960

Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1.

M L C Dal-Cól1, L Orlandi Pereira, V P Rosa, A V Calixto, A P Carobrez, M S Faria.   

Abstract

The influence of the first exposure length upon the effect of midazolam (MDZ) administration prior to the second exposure in the elevated plus-maze (EPM) was investigated. Drug-free rats were assigned to freely explore the EPM for 1, 2 or 5 min (Trial 1). Twenty-four hours later, each group was subdivided in two further groups, which were retested in the EPM for 5 min, 30 min after either saline or MDZ (1.5 mg kg(-1)) administration (Trial 2). The data showed that during Trial 2, the percentage of entries (%Open arm entries) and time spent in the open arms (%Open arm time) were decreased if rats were pre-exposed to the EPM for 2- or 5-min Trial 1, while the group submitted to 1-min Trial 1 length displayed decreased %Open arm time only. The anxiolytic effect of MDZ prior to Trial 2 was present in the group submitted to 1-min, impaired in the group submitted to 2-min and absent in the group submitted to 5-min Trial 1 length. Data are analyzed taking into account the emotional learning which underlies the exploratory behavior during the EPM Trial 2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479960     DOI: 10.1016/s0091-3057(02)01009-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.

Authors:  Leandro J Bertoglio; Antonio P Carobrez
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

2.  Effects of NMDA receptor blockade during the early development period on the retest performance of adult Wistar rats in the elevated plus maze.

Authors:  Sayad Kocahan; Kubra Akillioglu
Journal:  Neurochem Res       Date:  2013-04-26       Impact factor: 3.996

3.  A novel elevated plus-maze procedure to avoid the one-trial tolerance problem.

Authors:  Peggy Schneider; Ying-Jui Ho; Rainer Spanagel; Cornelius Rainer Pawlak
Journal:  Front Behav Neurosci       Date:  2011-07-27       Impact factor: 3.558

4.  Effects of test experience, closed-arm wall color, and illumination level on behavior and plasma corticosterone response in an elevated plus maze in male C57BL/6J mice: a challenge against conventional interpretation of the test.

Authors:  Hirotaka Shoji; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2021-02-15       Impact factor: 4.041

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.